GM3 synthase deficiency in non-Amish patients - Archive ouverte HAL Access content directly
Journal Articles Genetics in Medicine Year : 2021

GM3 synthase deficiency in non-Amish patients

(1) , (2) , (3, 4) , (2) , (2) , (5) , (2) , (2) , (6, 7) , (2) , (1) , (1) , (8) , (8) , (8) , (8) , (9) , (9) , (1) , (10, 11) , (10, 11) , (10, 11) , (10, 11) , (12) , (1) , (10, 11) , (1) , (1, 13) , (14) , (15) , (15) , (1, 13) , (1, 13)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
D. Gras
  • Function : Author
L. Perrin
  • Function : Author
Y. Capri
  • Function : Author
A. Pervillé
  • Function : Author
L. Arnaud
L. La Selva
  • Function : Author

Abstract

PURPOSE: Biallelic loss-of-function variants in ST3GAL5 cause GM3 synthase deficiency (GM3SD) responsible for Amish infantile epilepsy syndrome. All Amish patients carry the homozygous p.(Arg288Ter) variant arising from a founder effect. To date only 10 patients from 4 non-Amish families have been reported. Thus, the phenotypical spectrum of GM3SD due to other variants and other genetic backgrounds is still poorly known. METHODS: We collected clinical and molecular data from 16 non-Amish patients with pathogenic ST3GAL5 variants resulting in GM3SD. RESULTS: We identified 12 families originating from Reunion Island, Ivory Coast, Italy, and Algeria and carrying 6 ST3GAL5 variants, 5 of which were novel. Genealogical investigations and/or haplotype analyses showed that 3 of these variants were founder alleles. Glycosphingolipids quantification in patients' plasma confirmed the pathogenicity of 4 novel variants. All patients (N = 16), aged 2 to 12 years, had severe to profound intellectual disability, 14 of 16 had a hyperkinetic movement disorder, 11 of 16 had epilepsy and 9 of 16 had microcephaly. Other main features were progressive skin pigmentation anomalies, optic atrophy or pale papillae, and hearing loss. CONCLUSION: The phenotype of non-Amish patients with GM3SD is similar to the Amish infantile epilepsy syndrome, which suggests that GM3SD is associated with a narrow and severe clinical spectrum.
Embargoed file
Embargoed file
Ne sera jamais visible

Dates and versions

inserm-03587211 , version 1 (24-02-2022)

Identifiers

Cite

S. Heide, M. L. Jacquemont, D. Cheillan, M. Renouil, M. Tallot, et al.. GM3 synthase deficiency in non-Amish patients. Genetics in Medicine, 2021, 24 (2), pp.492-498. ⟨10.1016/j.gim.2021.10.007⟩. ⟨inserm-03587211⟩
33 View
2 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More